{"title":"RhD变异33型受体异体免疫产生抗d、抗e混合抗体的研究","authors":"Jian-Cheng Liu, Feng Shao","doi":"10.19746/j.cnki.issn.1009-2137.2024.06.034","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the cause of the production of anti-D and anti-E mixed antibody in an RhD positive patient.</p><p><strong>Methods: </strong>The ABO/Rh blood group typing and irregular antibody specificity were identified by conventional serological methods, the <i>RHD</i> gene exon 1-10 and heterozygous analysis were performed by sequence-specific primer polymerase chain reaction (PCR-SSP), and the whole exon sequence was analyzed by first-generation sequencing.</p><p><strong>Results: </strong>The patient's Rh blood group was weak D Type33, with the allele was <i>RHD*01W.33</i>, the patients was found to be <i>RhD<sup>+</sup>/RHD<sup>-</sup></i> heterozygous, with an Rh typing of Ccee, and the patient had developed anti-D combined with anti-E mixed antibodies.</p><p><strong>Conclusion: </strong>The patient has A c.520G>A mutation in exon 4 of the <i>RHD</i> gene, to lead decreased expression of RhD antigen in red blood cells and the anti-D and anti-E mixed antibodies were produced by transfusion immunostimulation.</p>","PeriodicalId":35777,"journal":{"name":"中国实验血液学杂志","volume":"32 6","pages":"1859-1864"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Study on the Production of Anti-D and Anti-E Mixed Antibodies by Alloimmunization in RhD Variant Type33 Recipients].\",\"authors\":\"Jian-Cheng Liu, Feng Shao\",\"doi\":\"10.19746/j.cnki.issn.1009-2137.2024.06.034\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To investigate the cause of the production of anti-D and anti-E mixed antibody in an RhD positive patient.</p><p><strong>Methods: </strong>The ABO/Rh blood group typing and irregular antibody specificity were identified by conventional serological methods, the <i>RHD</i> gene exon 1-10 and heterozygous analysis were performed by sequence-specific primer polymerase chain reaction (PCR-SSP), and the whole exon sequence was analyzed by first-generation sequencing.</p><p><strong>Results: </strong>The patient's Rh blood group was weak D Type33, with the allele was <i>RHD*01W.33</i>, the patients was found to be <i>RhD<sup>+</sup>/RHD<sup>-</sup></i> heterozygous, with an Rh typing of Ccee, and the patient had developed anti-D combined with anti-E mixed antibodies.</p><p><strong>Conclusion: </strong>The patient has A c.520G>A mutation in exon 4 of the <i>RHD</i> gene, to lead decreased expression of RhD antigen in red blood cells and the anti-D and anti-E mixed antibodies were produced by transfusion immunostimulation.</p>\",\"PeriodicalId\":35777,\"journal\":{\"name\":\"中国实验血液学杂志\",\"volume\":\"32 6\",\"pages\":\"1859-1864\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国实验血液学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.06.034\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国实验血液学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.06.034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
[Study on the Production of Anti-D and Anti-E Mixed Antibodies by Alloimmunization in RhD Variant Type33 Recipients].
Objective: To investigate the cause of the production of anti-D and anti-E mixed antibody in an RhD positive patient.
Methods: The ABO/Rh blood group typing and irregular antibody specificity were identified by conventional serological methods, the RHD gene exon 1-10 and heterozygous analysis were performed by sequence-specific primer polymerase chain reaction (PCR-SSP), and the whole exon sequence was analyzed by first-generation sequencing.
Results: The patient's Rh blood group was weak D Type33, with the allele was RHD*01W.33, the patients was found to be RhD+/RHD- heterozygous, with an Rh typing of Ccee, and the patient had developed anti-D combined with anti-E mixed antibodies.
Conclusion: The patient has A c.520G>A mutation in exon 4 of the RHD gene, to lead decreased expression of RhD antigen in red blood cells and the anti-D and anti-E mixed antibodies were produced by transfusion immunostimulation.